Last February Quotient Bioresearch was acquired by Pharmaron, a private, premier R&D CRO that has been helping life science clients worldwide since 2003. This acquisition allows Pharmaron to grow and develop services at the UK sites, as well as provide clients with a wider portfolio of services that span early discovery to later development.
Starting since beginnging of January, the Quotient Bioresearch logo has been replaced with the Pharmaron logo on the company website, emails, posters, white papers.
